WuXi Opening Offices in Boston and San Francisco
News Dec 19, 2014
WuXi PharmaTech (Cayman) Inc. has announced that it will open offices in Boston and San Francisco in early 2015. These new offices will give the company greater access to innovative companies in the world's two leading biotech hubs, both as customers and as investments.
In October, WuXi has announced that it had opened an office in Israel to tap into the biotech community there. In addition, the company has U.S. facilities in St. Paul, Philadelphia, Atlanta, Plainsboro (NJ), and San Diego.
"Our vision is to enable anyone and any company to discover and develop healthcare products to benefit the world's patients," said Dr. Ge Li, Chairman and CEO of WuXi PharmaTech. "These new offices bring our comprehensive platform of integrated R&D services closer to where entrepreneurs are and where cutting-edge science is being done."
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018